Barts Cancer Institute - Queen Mary University of London

Thursday Seminar Series
2019-01-17 12:30 - 13:30 (Europe/London) | Lister and Young Seminar Room, John Vane Science Centre, London, EC1M 6BQ
As part of the BCC’s Seminar Series, we are pleased to welcome Professor Tim Elliott from the University of Southampton to present at the BCC on Thursday 17th January. For more information about Professor Tim Elliott’s research, please click here.
The seminar is titled: ‘Peptide selection in the MHC I antigen processing pathway and its relevance to cancer’

Medicine at the Crick
2018-06-28 14:30 - 19:00 UTC | Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, United Kingdom
We are pleased to invite you and any interested colleagues to attend our inaugural ‘Medicine at the Crick’ event, entitled “Gene and Gene-Editing Therapy: A new challenge and opportunity in Clinical Medicine”, to be held on Thursday 28 June 2018, 2.30pm-7pm, at the Francis Crick Institute, London.
Our new ‘Medicine at the Crick‘ event series aims to showcase major advances in biomedical science and raise awareness of the medical implications of major scientific advances amongst the Crick and wider UK biomedical community.
The format is a series of short talks, followed by a keynote lecture and a panel discussion. We chose the theme of gene therapy and gene editing to launch the series. The event will be led by Professor Robin Lovell-Badge from the Crick and the keynote lecture will be given by Professor Matthew Porteus from Stanford University. Other speakers and panellists include Dr Claire Booth (UCL Great Ormond Street Institute of Child Health), Professor Sarah Tabrizi (UCL Institute of Neurology), Dr Sarah Chan (University of Edinburgh) and Nick Meade (Genetic Alliance UK).
For full information on the programme, and to order your free tickets for the event, please visit our Medicine at the Crick webpages or contact us on medicine-at-crick@crick.ac.uk

Joint Pancreas Meeting
2018-06-13 12:00 - 13:00 UTC | Room G.06, Rotblat building, Charterhouse Square
In this month’s meeting, Peng Liu- Centre for Molecular Oncology- will be speaking.
Title: Development of a novel prime-boost cancer vaccination regime for pancreatic cancer
This will take place in room G.06, Rotblat building.
We look forward to seeing you there.

‘Immune cell metabolism in health and disease’
2018-05-30 14:00 - 18:00 UTC | Imperial College London, South Kensington Campus, Imperial College London, Exhibition Road, London, SW7 2AZ, United Kingdom
The British Society for Immunology’s London Immunology Group is pleased to present ‘Immune cell metabolism in health and disease‘ taking place on Wednesday 30 May 2018 at Imperial College London, South Kensington Campus, 14.00 – 18.00pm.
Immunometabolism is an emerging field that investigates how the metabolic processes of immune cells affect their roles in disease. Interest in this field is gaining momentum due to the realisation that changes in how cells utilise energy underlies many inflammatory responses, and that manipulating cellular metabolism can beneficially enhance or reduce inflammation. During this half day meeting, we will discuss how the inflammatory environment and cellular metabolism are integrated to regulate immune cell function. It is anticipated this meeting will be of broad interest to researchers working in the fields of immunology and/or metabolism and those interested in therapeutic approaches which target metabolic processes.
For more information and registration, please click here

Joint Pancreas Meeting
2018-05-16 12:00 - 13:00 UTC | Room G.06, Rotblat building, Charterhouse Square
In this month’s meeting, we will hear from Louisa Chard- Centre for Molecular Oncology.
Title: Systemic oncolytic virotherapy using a novel IL21-armed Vaccinia virus vector as a potential therapeutic for pancreatic cancer
This will take place in room G.06, Rotblat building.
We look forward to seeing you there.

Thursday Seminar Series
2018-03-22 12:30 - 13:30 UTC
For this week’s installment of the BCI’s Thursday Seminar Series, Prof. Mark Cragg – Professor of Experimental Cancer Research and Director of the i4PhD Cancer Immunology Pathway – shall be speaking. Prof. Cragg’s research group is interested in two main areas: antibodies and small molecule inhibitors with the aim of understanding how these therapeutics function to delete tumour cells and how they might be augmented.
This seminar shall be in the Lister and Young Seminar Room, from 12.30pm-1.30pm.
Title: TBC
For more information about Prof. Mark Cragg, please click HERE.
